FOXM1 predicts disease progression in non-muscle invasive bladder cancer

被引：0
作者：
Sebastien Rinaldetti
Ralph Wirtz
Thomas Stefan Worst
Arndt Hartmann
Johannes Breyer
Lars Dyrskjot
Philipp Erben
机构：
[1] University of Heidelberg,Department of Hematology and Oncology, University Medical Centre Mannheim, Medical Faculty Mannheim
[2] Stratifyer Molecular Pathology,Department of Urology, University Medical Centre Mannheim, Medical Faculty Mannheim
[3] University of Heidelberg,Institute of Pathology
[4] University Hospital Erlangen,Department of Urology
[5] University of Regensburg,Department of Molecular Medicine
[6] Aarhus University Hospital,Department of Clinical Medicine
[7] Aarhus University,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2018年 / 144卷
关键词：
Molecular subtypes; FOXM1; Progression-free survival; Biomarker; Bladder cancer; MKI67;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1701 / 1709
页数：8
相关论文
共 50 条
[21]   Perfusion drugs for non-muscle invasive bladder cancer (Review) [J].
Qian, Jingyuan ;
Zhang, Qiuchen ;
Cao, Yang ;
Chu, Xi ;
Gao, Yiyang ;
Xu, Haifei ;
Cai, Hongzhou ;
Wu, Jiajia .
ONCOLOGY LETTERS, 2024, 27 (06)
[22]   Immunotherapy of High Risk Non-Muscle Invasive Bladder Cancer [J].
Ahdoot, Michael ;
Theodorescu, Dan .
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2021, 14 (11) :1345-1352
[23]   The role of pelvic lymphadenectomy in non-muscle invasive bladder cancer [J].
Lin, James ;
Deibert, Christopher M. ;
Holder, Dara ;
Benson, Mitchell C. ;
McKiernan, James M. .
CANADIAN JOURNAL OF UROLOGY, 2014, 21 (01) :7108-7113
[24]   Current Concepts in the Management of Non-Muscle Invasive Bladder Cancer [J].
Mandhani A. .
Indian Journal of Surgical Oncology, 2017, 8 (3) :397-402
[25]   Review on gender differences in non-muscle invasive bladder cancer [J].
Bilski, Konrad ;
Zapala, Lukasz ;
Skrzypczyk, Michal A. ;
Oszczudlowski, Maciej ;
Dobruch, Jakub .
TRANSLATIONAL ANDROLOGY AND UROLOGY, 2019, 8 (01) :12-20
[26]   RNA-based urinary assays for non-muscle invasive bladder cancer [J].
Pijpers, Olga M. ;
de Jong, Joep J. ;
Zuiverloon, Tahlita C. M. ;
Boormans, Joost L. .
CURRENT OPINION IN UROLOGY, 2022, 32 (05) :523-530
[27]   Cancer of the urinary bladder: Epidemiology, etiology, diagnosis of non-muscle invasive bladder cancer [J].
Karl A. .
MMW - Fortschritte der Medizin, 2018, 160 (21-22) :43-46
[28]   Urinary Metabolic Signatures Detect Recurrences in Non-Muscle Invasive Bladder Cancer [J].
Loras, Alba ;
Carmen Martinez-Bisbal, M. ;
Quintas, Guillermo ;
Gil, Salvador ;
Martinez-Manez, Ramon ;
Luis Ruiz-Cerda, Jose .
CANCERS, 2019, 11 (07)
[29]   INFLUENCE OF P16 GENE METHYLATION ON THE RISK OF PROGRESSION OF NON-MUSCLE INVASIVE BLADDER CANCER [J].
Smal, Marharyta P. ;
Nikitchenko, Nataliya, V ;
Rolevich, Alexander L. ;
Nabebina, Tatiana L. ;
Krasny, Sergei A. ;
Goncharova, Roza, I .
DOKLADY NATSIONALNOI AKADEMII NAUK BELARUSI, 2018, 62 (03) :322-328
[30]   Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer [J].
Wun-Jae Kim ;
Eun-Jung Kim ;
Seon-Kyu Kim ;
Yong-June Kim ;
Yun-Sok Ha ;
Pildu Jeong ;
Min-Ju Kim ;
Seok-Joong Yun ;
Keon Myung Lee ;
Sung-Kwon Moon ;
Sang-Cheol Lee ;
Eun-Jong Cha ;
Suk-Chul Bae .
Molecular Cancer, 9
12345